Stocks and Investing Stocks and Investing
Thu, August 20, 2020

Jeffrey Hung Initiated (ACAD) at Buy and Held Target at $55 on, Aug 20th, 2020


Published on 2024-10-27 12:25:49 - WOPRAI, Jeffrey Hung
  Print publication without navigation


Jeffrey Hung of Morgan Stanley, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Buy and Held Target at $55 on, Aug 20th, 2020.

Jeffrey has made no other calls on ACAD in the last 4 months.



There are 6 other peers that have a rating on ACAD. Out of the 6 peers that are also analyzing ACAD, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jay Olson of "Oppenheimer" Maintained at Hold with Decreased Target to $42 on, Tuesday, July 21st, 2020


These are the ratings of the 5 analyists that currently disagree with Jeffrey


  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $52 on, Thursday, August 6th, 2020
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $60 on, Thursday, August 6th, 2020
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $61 on, Tuesday, July 21st, 2020
  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $55 on, Tuesday, July 21st, 2020
  • Paul Matteis of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $71 on, Tuesday, July 7th, 2020
Contributing Sources